News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
219,678 Results
Type
Article (13803)
Company Profile (23)
Press Release (205852)
Section
Business (72214)
Career Advice (552)
Deals (12550)
Drug Delivery (17)
Drug Development (26961)
Employer Resources (14)
FDA (5169)
Job Trends (4876)
News (117426)
Policy (9053)
Tag
Academia (547)
Africa (219)
Allergies (13)
Alliances (11345)
Alzheimer's disease (297)
Approvals (5164)
Arizona (34)
Artificial intelligence (13)
Asia (13421)
Australia (2100)
Bankruptcy (90)
Best Places to Work (3522)
Biosimilars (17)
Biotechnology (18)
C2C Services and Suppliers (28151)
California (447)
Canada (252)
Cancer (104)
Career advice (413)
Cell therapy (19)
China (40)
Clinical research (22380)
Collaboration (22)
Colorado (22)
Compensation (12)
Connecticut (22)
COVID-19 (652)
Cystic fibrosis (12)
Data (68)
Diabetes (20)
Diagnostics (1543)
Drug pricing (12)
Earnings (46742)
Employer resources (13)
Europe (32302)
Events (33339)
FDA (5201)
Florida (60)
Funding (18)
Georgia (17)
GLP-1 (178)
Government (989)
Healthcare (5243)
Hotbed/Location (151205)
Illinois (57)
Indiana (49)
Infectious disease (656)
Inflammatory bowel disease (25)
Interviews (90)
IPO (6985)
Job creations (1379)
Job search strategy (391)
Kansas (23)
Layoffs (95)
Legal (2162)
Lung cancer (22)
Maine (19)
Manufacturing (16)
Maryland (89)
Massachusetts (397)
Medical device (3658)
Medtech (3658)
Mergers & acquisitions (5519)
Metabolic disorders (67)
Michigan (45)
Minnesota (54)
Neuroscience (327)
New Hampshire (20)
New Jersey (135)
New York (164)
NextGen Class of 2024 (1323)
Non-profit (941)
North Carolina (122)
Northern California (229)
Obesity (38)
Ohio (20)
Opinion (46)
Peanut (12)
Pennsylvania (168)
People (11030)
Phase I (5841)
Phase II (9362)
Phase III (8373)
Pipeline (81)
Postmarket research (989)
Preclinical (2026)
Rare diseases (25)
Real estate (1400)
Regulatory (6117)
Research institute (491)
Resumes & cover letters (94)
South America (355)
Southern California (188)
Startups (794)
Texas (62)
United States (2132)
Utah (14)
Vaccines (120)
Washington State (72)
Weight loss (41)
Date
Last 7 days (114)
Last 30 days (955)
Last 365 days (11740)
2024 (7688)
2023 (12391)
2022 (15248)
2021 (16750)
2020 (15563)
2019 (11764)
2018 (8826)
2017 (8375)
2016 (7135)
2015 (9008)
2014 (27504)
2013 (35250)
2012 (5392)
2011 (5752)
2010 (5166)
219,678 Results for "14".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology
Waypoint Bio Launches with $14.5M to Turbocharge Drug Discovery using in vivo Spatial Pooled Screening Technology.
June 28, 2024
·
4 min read
Communiqué from the Annual General Meeting of AlzeCure Pharma on 14 May 2024
AlzeCure Pharma , 14 May 2024, the annual general meeting was held in AlzeCure Pharma AB .
May 14, 2024
·
8 min read
Genetown
Nuclera Awarded £1.14M Innovate UK Funding for Development of eProtein Discovery
Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop eProtein Discovery™ system, announced it has been awarded two highly competitive Innovate UK grants totaling £1.14M.
June 7, 2024
·
2 min read
Genetown
Allurion Announces Publication of New Data Demonstrating Lean Mass Gains in Patients Experiencing 14% Weight Loss
Allurion Technologies, Inc., a company dedicated to ending obesity, announced the publication of a study demonstrating an average lean mass gain of 5.6% in patients with an average weight loss of 14% at four months on the Allurion Program.
June 20, 2024
·
6 min read
Satellos Bioscience Announces Results of Annual and Special Meeting of Shareholders - May 14, 2024
Satellos Bioscience Inc. announced the results of its Annual and Special Meeting of Shareholders held today, May 14, 2024.
May 14, 2024
·
5 min read
Deals
IRADIMED CORPORATION Announces Uplisting to The Nasdaq Global MarketTrading to commence effective on the market open June 14, 2024
IRADIMED CORPORATION announced today its common stock will uplist and commence trading on the Nasdaq Global Market, effective June 14, 2024, and will continue under the ticker symbol “IRMD.”
June 7, 2024
·
5 min read
Biotech Beach
Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th
Artelo Biosciences, Inc. today announced that it will be participating in the 2024 Pharma Partnering Summit being held May 14th – 15th in San Diego, California.
May 10, 2024
·
3 min read
Business
Allonnia and Terra Systems Form Distribution Partnership for 1,4 D-Stroy™ In Situ Bioremediation Solution
Allonnia, the bio-ingenuity company dedicated to extracting value where others see waste, announced a North American distribution agreement with Terra Systems for Allonnia’s 1,4 D-Stroy™ in situ bioremediation solution.
May 30, 2024
·
3 min read
Lone Star Bio
Integer to Present at 2024 Bank of America Securities Healthcare Conference on May 14
Integer Holdings Corporation today announced participation in the 2024 Bank of America Securities Healthcare Conference, to be held May 14 – 16, 2024, in Las Vegas.
May 1, 2024
·
1 min read
Business
BioStem Technologies to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024Conference Call on Tuesday, May 14th, at 4:30 pm ET
BioStem Technologies Inc., a leading biotechnology company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, announced that it plans to release its first quarter 2024 financial results post-market on Tuesday, May 14, 2024.
May 7, 2024
·
4 min read
1 of 21,968
Next
